RUNX1 and acute lymphoblastic leukemia: The ETV6/RUNX1-positive ALL patient sub-group had on average 2.7-fold higher GATA2 expression, compared to the ETV6/RUNX1-negative group (p < 0.001); indicating a strong association between ETV6/RUNX1 and GATA2 expression in B-cell progenitor cells from ALL patients.